glp-1 agonists cancer risk GLP-1s tied to lower for 10 types of compared with insulin in type 2 diabetes Association between glucagon-like peptide-1 receptor
Description
Multivariate regression analysis found no association between 6month weight gain and clinical factors such as type 2 diabetes (DM2), metformin use, endocrine therapy use, clinical stage, and GLP1 RA use
The need for improved efficacy and fewer side effects also potentiates the development of novel drugs
Abhishek Kansara, an endocrinologist at Houston Methodist Hospital
Al-Aly joined host William Brangham to explore the findings of his study
Preoperative considerations of new long-acting glucagon-like peptide-1 receptor agonists in diabetes mellitus
